I think Warren Buffett is one of the world’s leading investors. He has identified the right times to invest via his Berkshire Hathaway business during bear markets. His advice is very useful for finding compelling ASX shares.

Good investing is usually about choosing good assets at attractive prices. We’re generally presented with the best prices when there’s a lot of uncertainty.

Warren Buffett once shared one of the most simple yet valuable pieces of advice:

Be fearful when others are greedy and greedy when others are fearful.

In other words, invest eagerly when most investors are cautious and be careful when the market looks bubbly and too excited.

With that in mind, I believe the two ASX shares below tick the boxes.

Johns Lyng Group Ltd (ASX: JLG)

The Johns Lyng share price has dropped close to 20% since 26 February 2024, as shown in the chart below.

The company specialises in building and restoring various properties and contents after damage caused by insured events such as weather, fire, and impact.

Clients include major insurance companies, commercial enterprises, local and state governments, body corporates/owners’ corporations and regular households.

Johns Lyng is effectively growing its market share in Australia and the United States. It was recently appointed to the Allstate emergency response and mitigation panel. Allstate is one of the largest insurance companies in the US.

The company’s catastrophe earnings can be pretty volatile – catastrophes are not consistent. However, the underlying core business is growing at a pleasing pace. In the FY24 first-half result, Johns Lyng reported that its normalised business-as-usual net profit after tax (NPAT) increased 15.8% to $25 million.

The estimate on Commsec suggests the business could generate earnings per share (EPS) of 20.5 cents in FY24 and reach 25 cents in FY26. This translates into a forward price/earnings (P/E) ratio for FY26 of 24, which I think is appealing for a business with a long growth runway that’s growing underlying earnings by double digits.

That’s why I believe Warren Buffett would be attracted to this growing industrial ASX share.

Collins Foods Ltd (ASX: CKF)

The chart below shows that the Collins Foods share price has dropped around 25% since January 2024, presenting an opportunity to buy into this fast-growing business.

Collins Foods operates an extensive network of KFCs in Australia and a growing KFC network in Europe. It also operates a small number of Taco Bells in Australia.

When it comes to businesses that operate through physical locations, like retailers or food places, we want to see that those existing locations are performing well. This can be measured through the same-store sales (SSS) metric.

In the FY24 first half result, Collins Foods revealed KFC Australia SSS growth of 6.6% and KFC Europe SSS growth of 8.8%. It’s also steadily adding more KFC outlets in Australia and Europe, improving its scale benefits.

That HY24 result saw the company’s revenue rise 14.3% to $696.5 million and underlying NPAT increase 28.7%.

Europe has a much bigger population than Australia, so I believe there’s scope for a significant increase in the number of stores in the region over the next decade.

According to Commsec, Collins Foods’ EPS is expected to rise by approximately 50% between FY24 and FY26, which would put the business at just 12x FY26’s estimated earnings. I believe Warren Buffett would be attracted to this sort of growth potential.

The post I’d use the Warren Buffett method and buy these 2 ASX shares appeared first on The Motley Fool Australia.

More reading

• Is Guzman y Gomez stock too expensive?
• 5 things to watch on the ASX 200 on Wednesday
• This ASX 200 share still looks cheap to me. But don’t just take my word for it!
• Investing like billionaire Bill Ackman: 2 ASX stocks ticking all boxes
• Now could be an opportunity to snap up overlooked ASX shares

Motley Fool contributor Tristan Harrison has positions in Collins Foods and Johns Lyng Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Johns Lyng Group. The Motley Fool Australia has recommended Collins Foods and Johns Lyng Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Pilbara Minerals Ltd (ASX: PLS) share price has seen significant volatility in the last couple of years. Just look at the chart below — in the last month alone, it has sunk around 20%.

Can profit generated in future years translate into a recovery for the lithium miner?

ASX mining shares are heavily exposed to commodity price movement regarding profit-making and investor confidence.

Mining costs typically don’t change much from month to month or even year to year. Therefore, changes on the revenue side can significantly increase or reduce profitability.

The lithium price has sunk over the past 18 months. In the quarterly update for the three months to 31 March 2024, the ASX lithium share revealed the realised price for its commodity had sunk 28% since the quarter ending 31 December 2023.

With the lithium price sinking and staying low, what has this done to the profit estimates for the next few years? Let’s examine what one broker thinks.

FY24 projection

The 2024 financial year is nearly over, with only a couple of weeks left in June. However, until the reporting season arrives in August, we won’t see the company’s reported financials for several more weeks.

Broker UBS thinks Pilbara Minerals will generate $353 million of net profit after tax (NPAT) in FY24, which could represent a $2 billion reduction year over year.

UBS has forecast the company’s net cash balance could drop to $936 million as it invests in its P680 and P1000 projects.

UBS thinks the lithium price has stabilised at levels largely consistent with Pilbara Minerals’ BMX auction result of US$1,106 per tonne.

At the current Pilbara Minerals share price, it’s valued at 27x FY24’s estimated earnings.

How about FY25?

According to UBS, the weak conditions are expected to continue into the 2025 financial year.

The broker expects the ASX lithium share to generate $366 million of net profit in FY25, $13 million more than in FY24.

UBS expects Pilbara Minerals to allocate another A$680 million in capital expenditures in FY25 to grow P1000.

The broker forecasts the ASX share’s cash balance will be A$1.25 billion at the end of FY25, with a net cash balance of A$708 million.

Expectations for FY26

The 2026 financial year could see the ASX lithium share’s revenue increase by around A$300 million, which could also help the earnings before interest and tax (EBIT) increase by approximately A$300 million to $826 million.

Pilbara Minerals is projected to generate a net profit of $543 million in FY26, which would represent a 48% year-over-year increase or $177 million in dollar terms.

The increased profit and winding down of P1000 capital spending could see the net cash balance jump to $1.2 billion.

UBS has also pencilled in a dividend payment of 5 cents per share with earnings per share (EPS) generation of 18 cents.

Finally, here’s the FY27 forecast

According to this series of forecasts, the 2027 financial year could be the best year.

Its revenue is forecast to increase again to almost $2 billion, which could unlock $1 billion of EBIT.

UBS has predicted that Pilbara Minerals could make a net profit after tax of $690 million in FY27, which would represent an increase of 27% year over year. If that happens, the broker predicts the company could declare an annual dividend per share of 9 cents.  

The post Here’s the earnings forecast out to 2027 for Pilbara Minerals shares appeared first on The Motley Fool Australia.

More reading

• These are the 10 most shorted ASX shares
• 3 reasons to be positive on ASX 200 shares in FY25 (and 3 to be wary)
• Where could the Pilbara Minerals share price be in 12 months?
• These are the 10 most shorted ASX shares
• What happened to Pilbara Minerals shares in May?

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Every investor has a different risk appetite. Some investors play it safe and buy low risk, defensive ASX stocks. Others are willing to risk a little for stronger potential returns. And a handful will seek the huge potential returns on offer from the speculative side of the market.

If you’re in the latter category, then it could be worth checking out the speculative ASX stock in this article.

That’s because the team at Bell Potter believes that it has the potential to almost double in value from current levels.

Which speculative ASX stock?

The company in question is Immutep Ltd (ASX: IMM). It is a $520 million, clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) immunotherapy for cancer and autoimmune disease.

Immutep’s eftilagimod alfa (efti) product is its proprietary soluble LAG-3 protein and MHC Class II agonist that stimulates both innate and adaptive immunity for the treatment of cancer.

Management notes that as a first-in-class antigen presenting cell (APC) activator, efti binds to MHC (major histocompatibility complex) Class II molecules on APC leading to activation and proliferation of CD8+ cytotoxic T cells, CD4+ helper T cells, dendritic cells, NK cells, and monocytes.

It also upregulates the expression of key biological molecules like IFN-Æ´ and CXCL10 that further boost the immune system’s ability to fight cancer.

What is the broker saying?

Bell Potter highlights that the speculative ASX stock is on the cusp of becoming a phase three company with a significant market opportunity. It notes:

At the end of CY24, IMM will transition into a Phase 3 company targeting one of the most lucrative oncology indications, first-line (1L) non-small cell lung cancer (NSCLC).

IMM will target all patients regardless of PD-L1 expression and test the regimen of Efti + pembrolizumab + chemo in ~750 patients. This is a positive choice in our view as it broadens the TAM to ~70k US patients diagnosed annually (or ~US$11b) and aims to improve upon the best standard of care currently available to patients, thereby speeding up Phase 3 recruitment and real-world adoption. Recruitment will start end-CY24/early-CY25.

The broker was also pleased to see that Immutep has successfully raised $100 million from investors recently. It believes this “improved balance sheet provides ~2.5 years of runway to end-CY26 (post Phase 3 futility analysis) and clears any perceived funding overhang in the near-term ahead of key readouts in HNSCC and beyond.”

Big potential returns

Bell Potter has responded to the above by reaffirming its speculative buy rating and 80 cents price target on the ASX stock.

Based on its current share price of 41%, this implies potential upside of 95% for investors over the next 12 months. It concludes:

With longer-term value being driven by the 1L NSCLC Phase 3, short-term attention now shifts to the imminent release of Phase 2b data by 30th June in head & neck cancer, where Efti + Keytruda is being evaluated head-to-head against Keytruda.

We maintain our BUY (speculative) recommendation and $0.80/share valuation. We remain positive ahead of the significant Ph2b readout due in the next ~2 weeks.

The post This speculative ASX stock could almost double in value appeared first on The Motley Fool Australia.

More reading

• Why Brainchip, Immutep, Liontown, and Xero shares are tumbling today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

I think one of the leading ASX-listed exchange-traded funds (ETFs) is the iShares Global 100 ETF (ASX: IOO).

Regular readers may already know that I’m a big fan of international ETFs, which can provide diversification with strong holdings at an attractive management cost.

The Australian share market is heavily concentrated on two sectors, with around half of the S&P/ASX 200 Index (ASX: XJO) weighted to ASX bank and mining shares. I think the IOO ETF could be a particularly good move for Aussies who don’t have much international share exposure.

The iShares Global 100 ETF invests in 100 of the largest global stocks from both developed and emerging markets.

Diversification and holdings

It’s invested in all of the large US tech giants that are now part of our lives in various ways, including Microsoft, Nvidia, Apple, Amazon.com and Alphabet.  

It also owns names such as Proctor & Gamble, Mastercard, Tencent, Samsung, Walmart, LVMH, McDonald’s, Caterpillar, HSBC and many more.

These holdings are some of the world’s most effective operators in their fields. Because of their excellent economic moats, it’s very hard for smaller challengers to hurt these industry giants.

What I particularly like about the IOO ETF is its significant exposure to technology, with a 43% weighting. While banks and miners are typically exposed to the same operational risks as their peers, US tech shares are much more diverse and have global earnings bases. Thanks to the intangible nature of many of their services, tech companies can achieve strong profit margins and grow revenue quickly.

In terms of the other sectors, five industries have an allocation of more than 5% inside the IOO ETF: healthcare (10.5%), consumer discretionary (9.9%), financials (8.7%), communication (8.4%), and consumer staples (7.5%).

While more than three-quarters of the portfolio is listed in the US, the underlying earnings are more evenly spread worldwide. For example, consider all the different countries in which Apple smartphones are sold.  

Excellent returns

We shouldn’t rely upon past performance as an indicator of future returns, but I believe the underlying quality of the IOO ETF’s holdings can help long-term returns continue to be compelling.

According to fund provider Blackrock, the IOO ETF has delivered an average return per annum of 14.95% over the decade to 31 May 2024. If someone had invested $1,000 a decade ago, they would have around $4,000 now.

Many of these companies generate strong profits and a pleasing return on equity (ROE), so further profit re-investment can help them grow even more in the future.

Investors often like to value a business based on how much profit they’re making, so rising earnings should translate into higher valuations over time.

Reasonable fee

It’s not the cheapest ASX ETF out there. The IOO ETF has an annual management fee of 0.40%.

I acknowledge other ETFs are cheaper, such as the Vanguard MSCI Index International Shares ETF (ASX: VGS) and the Vanguard US Total Market Shares Index (ASX: VTS).

However, the IOO ETF allocates more to the strongest businesses than the VGS ETF and has more global diversification than the VTS ETF.

I think this ASX ETF can provide a lot of elements that some Aussie investors may be missing in their portfolios.

The post Why the iShares Global 100 ETF (IOO) is a great long-term buy appeared first on The Motley Fool Australia.

More reading

• Is it too late to buy these soaring international shares ASX ETFs?

HSBC Holdings is an advertising partner of The Ascent, a Motley Fool company. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet, Amazon, Apple, Mastercard, Microsoft, Nvidia, Tencent, and Walmart. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended HSBC Holdings and has recommended the following options: long January 2025 $370 calls on Mastercard, long January 2026 $395 calls on Microsoft, short January 2025 $380 calls on Mastercard, and short January 2026 $405 calls on Microsoft. The Motley Fool Australia has recommended Alphabet, Amazon, Apple, Mastercard, Microsoft, Nvidia, and Vanguard Msci Index International Shares ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Shaver Shop Group Ltd (ASX: SSG) shares might be an excellent source of passive income in the coming years. The ASX dividend share could pay an enormous dividend yield in FY26 if a forecast proves correct.

One of the benefits of investing in ASX retail shares is that they typically trade on a lower price/earnings (P/E) ratio, which can help enable a greater dividend yield.

Shaver Shop is among the largest retailers of male and female hair removal products. It has more than 120 stores in Australia and New Zealand and an online presence on its own websites, as well as eBay, Amazon, TradeMe, and MyDeal.

The company also offers oral care, hair care, massage, air treatment, and beauty products.

Low valuation

I mentioned retailers can have low P/E ratios, and Shaver Shop is no exception.

According to the estimate on Commsec, Shaver Shop is projected to generate earnings per share (EPS) of 13.2 cents in FY26.

At the current Shaver Shop share price of $1.14, that translates into the company trading at 10x FY26’s estimated earnings, which I think represents a low valuation considering the ASX dividend share could generate EPS growth between now and FY26.

Growing businesses are normally valued at a higher earnings multiple by investors to take into account the potential profit the business may make in the future.

Large dividend yield expected

No business is guaranteed to pay a dividend – it’s not bank interest.

Interestingly, Shaver Shop has grown its annual dividend every year since it first started paying one in 2017. This growth streak is not guaranteed to continue. Indeed, the estimates on Commsec imply a dividend cut may be on the cards in FY24, though the FY24 interim payout was maintained at 4.7 cents per share.  

The forecast on Commsec suggests Shaver Shop could pay an annual dividend per share of 10 cents in FY26. This would translate into a grossed-up dividend yield of 12.6%.

If that payout happens, it would be a huge yield for shareholders, but it could certainly be possible considering the last 12 months amounted to a grossed-up dividend yield of 12.8% amid difficult retailing conditions.

Shaver Shop can grow its profit in the future by adding more stores, benefiting from Australia’s growing population and adding more brands to its portfolio, such as Skull Shaver.

The post This ASX dividend share is predicted to pay a 12% yield in 2026! appeared first on The Motley Fool Australia.

More reading

• 2 ASX dividend shares that could create $1,000 in passive income in 2024

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Amazon. The Motley Fool Australia has recommended Amazon and Shaver Shop Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

If you’re looking to diversify your investment portfolio with some mining sector exposure, then it could be worth considering the two ASX 200 mining stocks named below.

That’s because they have not only been rated as top buys, but they also have been tipped to rise strongly from current levels. This could potential mean market-beating returns for investors buying them today.

Here’s what you need to know about these mining stocks:

Regis Resources Ltd (ASX: RRL)

Analysts at Bell Potter think this ASX 200 gold mining stock could be severely undervalued by the market right now.

It feels that investors are not taking into account its high-quality all-Australian portfolio and the attractiveness of these assets to a bigger player. In addition, the broker highlights that the Duketon Gold Project owner has a very positive production growth outlook. It said:

As one of the largest ASX listed gold producers, we are attracted to its all-Australian asset portfolio and organic growth options which are unique at this scale. Furthermore, we see key opportunities in the fundamental, medium-term outlook and, in our view, these may also make RRL an appealing corporate target in the current conducive M&A environment.

Bell Potter has a buy rating and $2.80 price target on its shares. This implies potential upside of 61% for investors over the next 12 months.

Woodside Energy Group Ltd (ASX: WDS)

Another ASX 200 mining stock that gets the thumbs up by analysts is Woodside. It is one of the world’s largest energy producers with operations across the globe.

Morgans thinks that its shares are undervalued after recent weakness. In light of this, it sees now as a great opportunity for investors to snap them up. It said:

WDS’s share price has been under pressure in recent months from a combination of oil price volatility and approval issues at Scarborough, its key offshore growth project. With both of those factors now having moderated, with the pullback in oil prices moderating and work at Scarborough back underway, we see now as a good time to add to positions. Increasing our conviction in our call is the progress WDS is making through the current capex phase, while maintaining a healthy balance sheet and healthy dividend profile.

The broker has an add rating and $36.00 price target on Woodside’s shares. Based on its current share price of $27.26, this suggests that a return of 32% is on the cards for investors before dividends. This increases to approximately 36% including them.

The post These ASX 200 mining stocks could rise 30% to 60% appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Monday
• Tax-busters: 5 fully-franked ASX dividend shares I’d buy for FY25
• Woodside shares hit a multi-year low this week, should you buy?
• 5 things to watch on the ASX 200 on Thursday
• Here are the top 10 ASX 200 shares today

Motley Fool contributor James Mickleboro has positions in Woodside Energy Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The benchmark ASX 200 index is home to 200 of the largest listed companies on the Australian share market.

Among these companies are some true blue chip stars that could form the foundations for a winning portfolio.

But which ASX 200 shares could be top buys for investors today today? Let’s now take a look at three blue chip options for investors to consider buying:

Coles Group Ltd (ASX: COL)

The team at Bell Potter thinks that Coles could be an ASX 200 share to buy.

It is of course one of Australia’s largest supermarket operators. In addition, the company has a large liquor store network and joint ownership of the Flybuys loyalty program.

The broker likes the company due partly to its recent investment in automation and its online business. It believes that this “should help Coles maintain its market position.”

Bell Potter currently has a buy rating and $19.00 price target on the company’s shares.

CSL Limited (ASX: CSL)

Another ASX 200 share that analysts rate as a buy is CSL.

It is one of the world’s leading biotherapeutics companies with a collection of industry-leading therapies. This includes therapies such as Privigen, Hizentra, Idelvion, and Afstyla.

But CSL is never one to settle. Each year it reinvests in the region of 12% of its sales back into research and development (R&D) activities. Combined with its existing products and the rollout of its new plasma collection technology, the future looks bright for this ASX 200 blue chip star.

In light of this, it may not come as no surprise to learn that a large number of brokers are recommending CSL shares as a buy. One of those is Macquarie, which has an overweight rating and $330.00 price target on them.

ResMed Inc. (ASX: RMD)

A third ASX 200 share that could be a great addition to a portfolio is ResMed.

It is a medical device company with a focus on the sleep disorder market. This is a huge market, with an estimated one in five people suffering from a sleep disorder globally.

However, the majority of these people are not aware of their conditions. But with the awareness of sleep disorders and the health risks they pose increasing each year, ResMed looks well-placed to continue its solid growth long into the future.

Citi is bullish on ResMed and has a buy rating and $36.00 price target on its shares.

The post 3 of the best ASX 200 blue chip shares to buy now appeared first on The Motley Fool Australia.

More reading

• 3 reasons to be positive on ASX 200 shares in FY25 (and 3 to be wary)
• Where Aussies are spending their money, and the ASX shares that could benefit
• 3 steps to take for a rich retirement with ASX shares
• Why Telstra and these excellent ASX dividend stocks could be buys
• Buying Coles shares? Here are key metrics you’ll want to know

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in CSL and ResMed. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Macquarie Group, and ResMed. The Motley Fool Australia has positions in and has recommended Coles Group, Macquarie Group, and ResMed. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

At the start of each week, I like to look at ASIC’s short position report to find out which shares are being targeted by short sellers.

This is because I believe it is well worth keeping a close eye on short interest levels as high levels can sometimes be a sign that something isn’t quite right with a company.

With that in mind, here are the 10 most shorted shares on the ASX this week according to ASIC:

• Pilbara Minerals Ltd (ASX: PLS) is far and away the most shorted share on the Australian share market with short interest of 21.6%. This is up slightly week on week. Short sellers appear to be betting on lithium prices staying lower for longer and crunching the company’s profits.
• IDP Education Ltd (ASX: IEL) has 13.1% of its shares held short, which is up slightly since last week. This language testing and student placement company recently revealed that it is being negatively impacted by student visa changes in a number of key markets. As a result, flat earnings and expected by analysts this year and an earnings decline is forecast the year after.
• Liontown Resources Ltd (ASX: LTR) has 10.4% of its share held short, which is up slightly week on week once again. The company will shortly commence lithium production at the Kathleen Valley Project. This isn’t perhaps the best time to be adding to lithium supply.
• Syrah Resources Ltd (ASX: SYR) has short interest of 10.2%, which is down week on week again. This graphite miner’s shares have fallen heavily over the last 12 months due to weak battery materials prices, production suspensions, and its ongoing cash burn.
• Flight Centre Travel Group Ltd (ASX: FLT) has seen its short interest rebound to 10%. Short sellers appear to believe that the travel agent will fall short of the market’s revenue margin expectations.
• Westgold Resources Ltd (ASX: WGX) has short interest of 10%, which is now up for a sixth week in a row. Doubts over the gold miner’s proposed merger with Canada-based Karoa Resources appear to be behind this.
• Sayona Mining Ltd (ASX: SYA) has short interest of 9.7%, which is up since last week. This lithium miner is currently paying more to pull lithium out of the ground than it receives from buyers. Not a great business model.
• Chalice Mining Ltd (ASX: CHN) has short interest of 9.6%, which is up week on week again. While this mineral exploration company’s Gonneville Project is a globally significant critical minerals project, it is still years away from commencing production or even a final investment decision. Some investors also believe the assumptions used its project studies are a touch ambitious.
• Australian Clinical Labs Ltd (ASX: ACL) has short interest of 8.4%, which is down slightly since last week. This struggling health imaging company is guiding to yet another sharp decline in its earnings in FY 2024.
• Weebit Nano Ltd (ASX: WBT) returns to the top ten with 8.3% of its shares held short. This semiconductor company’s shares have crashed 70% over the last 12 months. Short sellers don’t appear to believe the declines are over given its lofty valuation and pitiful revenue generation.

The post These are the 10 most shorted ASX shares appeared first on The Motley Fool Australia.

More reading

• 3 reasons to be positive on ASX 200 shares in FY25 (and 3 to be wary)
• With nothing in my savings account, I’d use Warren Buffett’s golden rule to build wealth
• Brokers name 3 ASX dividend shares to buy
• Here are the top 10 ASX 200 shares today
• Where could the Pilbara Minerals share price be in 12 months?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Idp Education. The Motley Fool Australia has recommended Flight Centre Travel Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Australian tech sector is home to a number of ASX shares that have significant growth potential.

This could make them great options for investors that are willing to make patient buy and hold investments.

For example, three ASX tech stocks that brokers think have very bright futures and could be in the buy zone now are listed below.

Here’s what you need to know about them:

Life360 Inc (ASX: 360)

Life360 could be a fantastic ASX tech stock to buy.

It is the location technology company behind the eponymous Life360 app. This app is used by millions of families worldwide. A recent update revealed that its global monthly active users (MAU) increased by 4.9 million during the first quarter to 66.4 million.

This is underpinning significant revenue and earnings growth. And with management focusing on increasing both its average revenue per user metric and paid subscribers, as well as venturing into advertising, Life360’s growth outlook appears very positive.

Morgan Stanley is confident on its outlook and recently put an overweight rating and $17.50 price target on its shares.

Megaport Ltd (ASX: MP1)

The second ASX tech stock that could be a buy is Megaport.

It is the leading global provider of elastic interconnection services. Megaport’s software layer provides users with an easy way to create and manage network connections. Through its network, businesses can deploy private point-to-point connectivity between any of the locations on Megaport’s global network infrastructure.

Due to the structural shift to the cloud and higher spending on enterprise networking, the company has been growing at a rapid rate and appears well-placed to continue doing so in the coming years.

Citi is a big fan of the company and believes there will be a multi-year spend on cloud infrastructure coming and this will support structural growth for Megaport.

The broker put a buy rating and $16.05 price target on its shares last week.

Xero Ltd (ASX: XRO)

A third ASX tech stock that analysts rate as a buy is Xero.

It is a global small business platform with a total of 4.2 million subscribers. The company notes that its smart tools help small businesses and their advisors to manage core accounting functions like tax and bank reconciliation. In addition, they can complete other important small business tasks like payroll and payments.

Goldman Sachs is very bullish about the company due largely to its quality and significant growth opportunity.

Its analysts highlight that Xero is “very well-placed to take advantage of the digitisation of SMBs globally, driven by compelling efficiency benefits and regulatory tailwinds, with >100mn SMBs worldwide representing a >NZ$100bn TAM.”

Goldman currently has a buy rating and $164.00 price target on its shares.

The post 3 explosive ASX tech stocks to buy and hold forever appeared first on The Motley Fool Australia.

More reading

• Why Xero could be one the best shares to buy in the Asia-Pacific
• Top ASX AI stocks to buy in June 2024
• Here are the top 10 ASX 200 shares today
• Brokers name 3 ASX shares to buy now
• Why Boss Energy, Judo Capital, Life360, and Paladin Energy shares are pushing higher

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in Life360 and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Life360, Megaport, and Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Megaport. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.